Comparing the current results to its competitors, Prophase Labs Inc reported Revenue decrease in the 2 quarter 2026 year on year by -18.93 %, despite the revenue increase by the most of its competitors of 10.41 %, recorded in the same quarter.
Prophase Labs Inc 's Comment on Competition and Industry Peers
The company operates in a competitive personal genomics market that includes competitors such as Interpace Biosciences, Inc. These competitors range from established diagnostic and laboratory service providers to new entrants offering direct-access, consumer self-pay tests, and genetic interpretation services. Some competitors possess longer operating histories and greater financial, technical, and marketing resources, enabling them to respond more rapidly to technological advancements, conduct extensive research and development, implement broader marketing campaigns, and adopt aggressive pricing strategies. This competitive environment may result in the development of similar or more widely accepted products and services by competitors, potentially reducing the company's market share.
In the pharmaceutical industry, competition is intense and characterized by rapid innovation. Potential competitors include major multinational pharmaceutical companies, established biotechnology firms, specialty pharmaceutical companies, universities, and research institutions. Many of these competitors have substantially greater resources, including larger research and development staffs, manufacturing capabilities, and experienced marketing organizations. Smaller or early-stage companies may also pose significant competition, particularly through collaborations with larger companies possessing greater resources. Additionally, mergers and acquisitions within the biotechnology and pharmaceutical sectors may further influence the competitive landscape.
Abbott Laboratories operates as a diversified healthcare company with a focus on developing and manufacturing a wide range of health-related products, including pharmaceuticals, medical devices, nutritional products, and diagnostic technologies. Their business model emphasizes innovation and quality, aiming to address the diverse needs of patients and healthcare providers across various sectors globally. By leveraging their expertise and extensive portfolio, Abbott strives to enhance patient outcomes and improve the overall quality of life.
Evofem Biosciences Inc's business model focuses on the development and commercialization of innovative products in the women's sexual and reproductive health sector.
Quest Diagnostics Inc operates as a leading provider of clinical laboratory and diagnostic information services, catering to patients, healthcare professionals, hospitals, and pharmaceutical companies. The company generates revenue through a comprehensive suite of diagnostic testing services, encompassing routine lab tests, advanced molecular diagnostics, and a variety of specialized tests tailored to support clinical decision-making and patient care.
Hologic Incs business model focuses on developing and commercializing medical technologies and diagnostic products, primarily dedicated to womens healthcare. Their offerings include innovative solutions for breast and skeletal health, gynecological health, and surgical products, aiming to improve patient outcomes and enhance healthcare practices.
Labcorp Holdings Inc operates as a major healthcare diagnostics company, providing clinical laboratory tests and services to healthcare providers, pharmaceutical companies, and government agencies. Their business model emphasizes delivering accurate and timely test results to aid in patient diagnosis, treatment, and monitoring.
Sources:
Prophase Labs Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Prophase Labs Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
